| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $1.17B | +21.1% |
| Cost of Revenue | $299.9M | +16.5% |
| Gross Profit | $866.8M | +22.8% |
| R&D Expense | $481.7M | +14.4% |
| SG&A Expense | $172.7M | +10.2% |
| Operating Income | -$380.1M | +9.3% |
| Pre-tax Income | -$300.7M | +10.2% |
| Income Tax | -$5.4M | -152.0% |
| Net Income | -$295.3M | +14.4% |
| EPS (Basic) | -$0.86 | +19.6% |
| EPS (Diluted) | -$0.86 | +19.6% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $347.2M | -10.0% |
| Accounts Receivable | $390.8M | +24.3% |
| Current Assets | $2.61B | +10.9% |
| Total Assets | $2.99B | +10.8% |
| Current Liabilities | $680.6M | +15.5% |
| Long-term Debt | $1.10B | +0.4% |
| Total Liabilities | $1.82B | +4.8% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $64.3M | +92.1% |
| Capital Expenditures | $3.6M | +40.1% |
| Investing Cash Flow | -$185.0M | -146.7% |
| Financing Cash Flow | $81.2M | +1.7% |
| Free Cash Flow | $60.7M | +96.4% |
| Stockholders' Equity |
| $1.17B |
| +21.6% |